RIO DE JANEIRO, BRAZIL - Chile’s health regulator on Wednesday, January 27th, approved the AstraZeneca-Oxford COVID-19 vaccine for emergency use among its population by a unanimous vote of its advisory board.
The vaccine has previously been approved by international regulators including in the UK, South African and Argentina.
The approval from the Chilean Public Health Institute (ISP) is for use for Chileans over the age of 18 and without an upper age limit.
Heriberto Garcia, director of the Public Health Institute (ISP), said the approval of the AZ drug - which is also undergoing late-stage human trials in . . .